litlas
Log inCreate account

Antonio Oliver

Active 1995–2025

214
Papers
24,662
Citations
86
h-index
196
i10-index

Citations

Citations per year for Antonio Oliver1980: 1 citations1990: 2 citations1998: 1 citations1999: 2 citations2000: 14 citations2001: 32 citations2002: 67 citations2003: 67 citations2004: 79 citations2005: 86 citations2006: 79 citations2007: 83 citations2008: 95 citations2009: 143 citations2010: 164 citations2011: 189 citations2012: 160 citations2013: 168 citations2014: 179 citations2015: 180 citations2016: 152 citations2017: 262 citations2018: 245 citations2019: 891 citations2020: 1,107 citations2021: 1,348 citations2022: 985 citations2023: 778 citations2024: 1,209 citations2025: 714 citations2026: 15 citations1981–1989: no citations, so these years are not shown1991–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,596 citing papers, 16.7% of this breakdownSpain: 949 citing papers, 10% of this breakdownUnited Kingdom: 648 citing papers, 6.8% of this breakdownChina: 616 citing papers, 6.5% of this breakdownItaly: 457 citing papers, 4.8% of this breakdownFrance: 446 citing papers, 4.7% of this breakdownGermany: 394 citing papers, 4.1% of this breakdownAustralia: 326 citing papers, 3.4% of this breakdownCanada: 303 citing papers, 3.2% of this breakdownIndia: 264 citing papers, 2.8% of this breakdownSwitzerland: 208 citing papers, 2.2% of this breakdownDenmark: 200 citing papers, 2.1% of this breakdown
0%16.7%Other 32.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology56.4%
  • Medicine25.2%
  • Environmental Science5%
  • Immunology and Microbiology4.1%
  • Mathematics2.1%
  • Engineering1.4%
  • Other5.8%

Topics

  • Antibiotic Resistance in Bacteria16.9%
  • Bacterial biofilms and quorum sensing8.3%
  • Antibiotics Pharmacokinetics and Efficacy5.2%
  • Antibiotic Use and Resistance4.2%
  • Bacterial Identification and Susceptibility Testing2.7%
  • SARS-CoV-2 and COVID-19 Research2.6%
  • Other60.1%

Coauthors

All papers

Open in search
  1. Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections

    Authors: Juan Pablo Horcajada, M. Montero, Antonio Oliver, Luisa Sorlí, Sònia Luque, Sílvia Gómez-Zorrilla, Natividad Benito, Santiago Grau - Clinical Microbiology Reviews 2019 cited by 956

  2. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update

    Authors: Ester del Barrio-Tofiño, Carla López-Causapé, Antonio Oliver - International Journal of Antimicrobial Agents 2020 cited by 371

  3. ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

    Authors: Niels Høiby, Thomas Bjarnsholt, Claus Moser, Gianluigi Li Bassi, Tom Coenye, G. Donelli, Luanne Hall‐Stoodley, Veronika Holá, Christine Imbert, Klaus Kirketerp‐Møller, David Lebeaux, Antonio Oliver, Andrew J. Ullmann, Craig Williams - Clinical Microbiology and Infection 2015 cited by 784

  4. The increasing threat of Pseudomonas aeruginosa high-risk clones

    Authors: Antonio Oliver, Xavier Mulet, Carla López-Causapé, Carlos Juan - Drug Resistance Updates 2015 cited by 651

  5. Antibiotic treatment of biofilm infections

    Authors: Oana Ciofu, Estrella Rojo‐Molinero, María D. Macià, Antonio Oliver - Apmis 2017 cited by 411

  6. Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning‐enabled molecular diagnostics

    Authors: Ariane Khaledi, Aaron Weimann, Monika Schniederjans, Ehsaneddin Asgari, Tzu‐Hao Kuo, Antonio Oliver, Gabriel Cabot, Axel Kola, Petra Gastmeier, Michael Hogardt, Daniel E Jonas, Mohammad RK Mofrad, Andreas Bremges, Alice C. McHardy, Susanne Häußler - EMBO Molecular Medicine 2020 cited by 190

  7. Antimicrobial susceptibility testing in biofilm-growing bacteria

    Authors: María D. Macià, Estrella Rojo‐Molinero, Antonio Oliver - Clinical Microbiology and Infection 2014 cited by 529

  8. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    Authors: Miquel Àngel Sastre-Femenía, Almudena Fernández-Muñoz, María A. Gomis-Font, Biel Taltavull, Carla López-Causapé, Jorge Arca-Suárez, Luis Martı́nez-Martı́nez, Rafael Cantón, Nieves Larrosa, Jesús Oteo, Laura Zamorano, Antonio Oliver, Fátima Galán‐Sánchez, Irene Gracia-Ahufinger, Luis Martı́nez-Martı́nez, Carmen Liébana-Martos, Carolina Roldán, Juan Manuel Sánchez Calvo, Encarnación Clavijo, Laura Mora-Navas, Javier Aznar, José Antonio Lepe, Ángel Rodríguez-Villodres, Esther Recacha, Francisco Javier Casas-Círia, Carmen Martínez-Rubio, M Sempere, Lina Martín-Hita, Cristina Seral, Ana Isabel López‐Calleja, Carmen Aspíroz, Marisa Monforte, Pedro de la Iglesia-Martínez, Gemma Jiménez-Guerra, Elena Riera-Pérez, Carmen Collado, Carmen Gallegos, Xavier Mulet, Almudena Fernández-Muñoz, Miquel Àngel Sastre-Femenía, María Antonia Gomis-Font, Laura Zamorano, Antonio Oliver, María Siller‐Ruiz, Jorge Calvo, Dolores Eliche‐Quesada, Jun Hao Wang-Wang, Cristina Pitart, Francesc Marco, Núria Prim, Juan Pablo Horcajada, Eduardo Padilla, Ester del Barrio-Tofiño, Belen Viñado-Pérez, Nieves Larrosa, Fé Tubau, Sílvia Capilla, Antonio Casabella, Mar Olga Pérez-Moreno, Emma Padilla, Mónica Ballestero, Alba Rivera, Ferrán Navarro, Fréderic Gómez-Bertomeu, Sergio Pardo-Granell, Ester Picó-Plana, Dolores Guerrero, Carolina Sarvisé-Buil, Alba Bellés Bellés, Marta Fernández-Esgueva, María del Pilar Ortega-Lafont, Inmaculada García, Noelia Arenal-Andrés, Susana Hernando-Real, Rosario Ibáñez, Jesús Martı́nez, Federico Becerra, Carmen Aldea-Mansilla, Asmaa Alaoui-Sosse, José Carlos González, Julia Guzmán-Puche, Miguel Ángel Blázquez-Andrada, Nora Mariela Martínez-Ramírez, Alicia Beteta, Bárbara Gomila-Sard, Salvador Giner Almaraz, Eugenio Garduño, Pedro Miguel Juiz-González, Jorge Arca-Suárez, J. Corpas Alba, Pilar Alonso, Ana Isabel Rodríguez, María Isabel Paz-Vidal, Marta García‐Campello, Pablo Camacho, María de los Ángeles Pallarés, María Luisa Pérez del Molino, Amparo Coira, Gema Barbeito, Anniris Rincón and 30 more - The Lancet Regional Health - Europe 2023 cited by 82

  9. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

    Authors: Jean Chastre, Bruno François, Marc Bourgeois, Apostolos Komnos, Ricard Ferrer, Galia Rahav, Nicolas De Schryver, Alain Lepape, İftihar Köksal, Charles‐Édouard Luyt, Miguel Sánchez García, Antoní Torres, Philippe Eggimann, Despoina Koulenti, Thomas L Holland, Omar Ali, Kathryn Shoemaker, Pin Ren, Julien Sauser, Alexey Ruzin, David E. Tabor, Ahmad Akhgar, Yuling Wu, Yu Jiang, Antonio DiGiandomenico, Susan Colbert, Drieke Vandamme, Frank E. J. Coenjaerts, Surbhi Malhotra‐Kumar, Leen Timbermont, Antonio Oliver, Olivier Barraud, Terramika Bellamy, Marc J. M. Bonten, Herman Goossens, Colin Reisner, Mark T. Esser, Hasan S. Jafri, The COMBACTE-MAGNET EVADE Study Group, Michael Joannidis, Walter Klimscha, Elisabeth De Waele, Jacques Devriendt, Vincent Huberlant, Pieter Depuydt, Sam Van Boxstael, Mladen Perić, Jasminka Kopić, Michal Hanauer, Tomas Hruby, Vladimír Šrámek, Petr Svoboda, Tomáš Vymazal, Martin Nováček, Djillali Annane, Jean‐Paul Mira, Bertrand Souweine, Pierre‐François Dequin, Ferhat Meziani, François Stéphan, Saadalla Nseir, Sébastien Gibot, Carole Schwebel, Gaëtan Plantefève, Jean‐Luc Diehl, Christian Richard, Christian Lamer, Kada Klouche, Samir Jaber, Epaminondas Zakynthinos, Georgios Filntisis, Spyros Zakynthinos, Antonia Koutsoukou, Georgios Saroglou, Charikleia Nikolaou, Glykeria Vlachogianni, Ioannis Pnevmatikos, Konstantinos Mandragos, Ildikó Krémer, Zsolt Dezso Rozgonyi, Zsuzsa Marjanek, Ignacio Martín‐Loeches, Pierre Singer, Vernon van Heerden, Yehuda Carmeli, Pedro Póvoa, Antonio Alvarez Seoane, Pedro Henrique de Moura, Filipe Gonzalez, Paula Ramírez, Antonio Torres Martí, Ricard Ferrer, Lorena Oteiza, D. Escudero, Enrique Piacentini, Paula Vera, Luis Tamayo, Miguel Angel Gonzalez Gallego, B. Suberviola Cañas, Iglesias Figueira and 18 more - Critical Care 2022 cited by 93

  10. The Versatile Mutational Resistome of Pseudomonas aeruginosa

    Authors: Carla López-Causapé, Gabriel Cabot, Ester del Barrio-Tofiño, Antonio Oliver - Frontiers in Microbiology 2018 cited by 258

  11. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms

    Authors: María Fernández-Billón, Aina E. Llambías-Cabot, Elena Jordana‐Lluch, Antonio Oliver, María D. Macià - Biofilm 2023 cited by 103

  12. Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group

    Authors: Antonio Oliver, Estrella Rojo‐Molinero, Jorge Arca-Suárez, Yeşim Besli, Pierre Bogaerts, Rafael Cantón, Cansu Çimen, P Croughs, Olivier Denis, Christian G. Giske, Tíscar Graells, Te‐Din Huang, Bogdan I. Iorga, Onur Karatuna, Béla Kocsis, Andreas Kronenberg, Carla López-Causapé, Surbhi Malhotra‐Kumar, Luis Martínez‐Martínez, Annarita Mazzariol, Sylvain Meyer, Thierry Naas, Daan W. Notermans, Jesús Oteo, Torunn Pedersen, Mateja Pirš, Patrícia Poeta, Laurent Poirel, Spyros Pournaras, Arnfinn Sundsfjord, Dóra Szabó, Arjana Tambić-Andrašević, Rossitza Vatcheva-Dobrevska, Astra Vitkauskienė, Katy Jeannot - Clinical Microbiology and Infection 2023 cited by 94

  13. Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa

    Authors: Cristina Lasarte-Monterrubio, Pablo A. Fraile-Ribot, Juan Carlos Vázquez-Ucha, Gabriel Cabot, Paula Guijarro-Sánchez, Isaac Alonso-García, Soraya Rumbo‐Feal, Fátima Galán‐Sánchez, Alejandro Beceiro, Jorge Arca-Suárez, Antonio Oliver, Germán Bou - Journal of Antimicrobial Chemotherapy 2022 cited by 53

  14. High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection

    Authors: Antonio Oliver, Rafael Cantón, Pilar Campo, Fernando Baquero, Jesús Blázquez - Science 2000 cited by 1,479

  15. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain

    Authors: Ester del Barrio-Tofiño, Carla López-Causapé, Gabriel Cabot, Alba Rivera, Natividad Benito, Concepción Segura, M. Montero, Luisa Sorlí, Fé Tubau, Sílvia Gómez-Zorrilla, Nuria Tormo, Raquel Durá-Navarro, Esther Viedma, Elena Resino-Foz, Marta Fernández-Martínez, Claudia González-Rico, Izaskun Alejo-Cancho, José Antonio Martínez, Cristina Labayru-Echverria, Carlos Dueñas, Ignacio Ayestarán, Laura Zamorano, Luis Martı́nez-Martı́nez, Juan Pablo Horcajada, Antonio Oliver - Antimicrobial Agents and Chemotherapy 2017 cited by 171

  16. Pseudomonas aeruginosa: a clinical and genomics update

    Authors: Andreu Coello Pelegrin, Mattia Palmieri, Caroline Mirande, Antonio Oliver, Pieter Moons, Herman Goossens, Alex van Belkum - FEMS Microbiology Reviews 2021 cited by 89

  17. In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa

    Authors: María A. Gomis-Font, Miquel Àngel Sastre-Femenía, Biel Taltavull, Gabriel Cabot, Antonio Oliver - Journal of Antimicrobial Chemotherapy 2023 cited by 47

  18. Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone

    Authors: Carla López-Causapé, Lea M. Sommer, Gabriel Cabot, Rosa Rubio, Alain A. Ocampo-Sosa, Helle Krogh Johansen, Joan Figuerola, Rafael Cantón, Timothy J. Kidd, Søren Molin, Antonio Oliver - Scientific Reports 2017 cited by 173

  19. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent “β-Lactam Enhancer” Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones

    Authors: Bartolomé Moyá, Isabel M. Barceló, Sachin Bhagwat, Mahesh Patel, Germán Bou, Krisztina M. Papp‐Wallace, Robert A. Bonomo, Antonio Oliver - Antimicrobial Agents and Chemotherapy 2017 cited by 131

  20. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

    Authors: Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto, Po‐Ren Hsueh, Pierluigi Viale, José Ramón Paño‐Pardo, Mario Venditti, Mario Tumbarello, George L. Daikos, Rafael Cantón, Yohei Doi, Felipe Francisco Tuon, Ilias Karaiskos, Elena Pérez‐Nadales, Mitchell J. Schwaber, Özlem Kurt Azap, Maria Souli, Emmanuel Roilides, Spyros Pournaras, Murat Akova, Federico Pérez, Joaquín Bermejo, Antonio Oliver, Manel Almela, Warren Lowman, Benito Almirante, Robert A. Bonomo, Yehuda Carmeli, David L. Paterson, Álvaro Pascual, Jesús Rodríguez‐Baño, M D del Toro, Juan Gálvez-Acebal, Marco Falcone, Alessandro Russo, Helen Giamarellou, Enrico Maria Trecarichi, Angela Raffaella Losito, Elisa García‐Vázquez, Alicia Hernández, J Gómez, Germán Bou, Εlias Iosifidis, Núria Prim, Ferrán Navarro, Beatriz Mirelis, Anna Skiada, Julia Origüen, R San Juan, Mario Fernández‐Ruiz, Nieves Larrosa, Mireia Puig‐Asensio, José Miguel Cisneros, José Molina, V. González, V. Rucci, E. Ruiz de Gopegui, C. Marinescu, Luis Martı́nez-Martı́nez, M.C. Fariñas, M.E. Cano, Mónica Gozalo, Marta Mora-Rillo, Carolina Navarro-San Francisco, Carmen Peña, Sílvia Gómez-Zorrilla, Fé Tubau, Athanasios Tsakris, Olympia Zarkotou, Anastasia Antoniadou, Garyphallia Poulakou, Johann Pitout, Divya Virmani, Julián Torre-Cisneros, Julia Guzmán-Puche, Özant Helvacı, Ahmet Şahin, Vicente Pintado, Pablo Ramos-Ruiz, Michele Bartoletti, Maddalena Giannella, E. Tacconelli, F Riemenschneider, Esther Calbo, Cristina Badía, Mariona Xercavins, Oriol Gasch, D. Fontanals, E. Jové - The Lancet Infectious Diseases 2017 cited by 521

  21. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens

    Authors: Lucía Blasco, Antón Ambroa, Rocío Trastoy, Inés Bleriot, Miriam Moscoso, Laura Fernández-García, Elena Pérez‐Nadales, Felipe Fernández-Cuenca, Julián Torre‐Cisneros, Jesús Oteo, Antonio Oliver, Rafael Cantón, Timothy J. Kidd, Ferrán Navarro, Elisenda Miró, Álvaro Pascual, Germán Bou, Luis Martı́nez-Martı́nez, María Tomás - Scientific Reports 2020 cited by 111

  22. Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients

    Authors: Julio Diaz Caballero, Rachel M. Wheatley, Natalia Kapel, Carla López-Causapé, Thomas van der Schalk, Angus Quinn, Liam P. Shaw, Lois Ogunlana, Claudia Recanatini, Basil Britto Xavier, Leen Timbermont, Jan Kluytmans, Alexey Ruzin, Mark T. Esser, Surbhi Malhotra‐Kumar, Antonio Oliver, R. Craig MacLean - Nature Communications 2023 cited by 68

  23. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    Authors: Javier E. Cañada-García, Zaira Moure, Pedro J. Sola‐Campoy, Mercedes Delgado-Valverde, M.E. Cano, Desirée Gijón, Mónica C. González, Irene Gracia-Ahufinger, Nieves Larrosa, Xavier Mulet, Cristina Pitart, Alba Rivera, Germán Bou, Jorge Calvo, Rafael Cantón, Juan José González‐López, Luis Martı́nez-Martı́nez, Ferrán Navarro, Antonio Oliver, Zaira R. Palacios‐Baena, Álvaro Pascual, Guillermo Ruíz-Carrascoso, Jordi Vilà, Belén Aracil, Marı́a Pérez-Vázquez, Jesús Oteo, the GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group - Frontiers in Microbiology 2022 cited by 65

  24. β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein

    Authors: Bartolomé Moyá, Andreas Dötsch, Carlos Juan, Jesús Blázquez, Laura Zamorano, Susanne Häußler, Antonio Oliver - PLoS Pathogens 2009 cited by 288